NSG 552 - Psychopharmacology
Exam 2
Question:
What disorder presents as: not fixated on body shape/weight, recurrent
episodes of binge eating, no compensatory behaviors (vomiting/laxatives/etc.), usually obese?
Answer:
Binge-eating disorder
Question:
What is the treatment for binge-eating disorder?
Answer:
First-line: SSRIs (escitalopram); Psychotherapy; Vyvanse= FDA approved/
topamx associated with weight loss/ orlistat inhibits pancreatic lipase by decreasing the amount of fat absorbed from GI tract
- / 4
Question:
What are the treatments for bulimia?
Answer:
CBT + antidepressants/ SSRIs (first-line treatment); Fluoxetine 60-80 mg/day= only FDA approved medication
Question:
What are characteristics of insomnia?
Answer:
Difficulty falling or remaining asleep/ acute insomnia <3 months, chronic insomnia > 3 months
Question:
What disorder presents as; binge-eating w/behaviors to counteract weight gain (vomit, laxatives, diuretics, etc), embarrassed by binge eating, overly concerned about body weight, usually maintains normal body weight or may be overweight
Answer:
Bulimia nervosa
- / 4
Question:
With OTC sedatives/hypnotics- does a tolerance to sedating effects develop rapidly?
Answer:
Yes
Question:
Which phase of sleep is eszopiclone (lunesta) used?
Answer:
Both- onset and maintenance
Question:
What is nonrestorative sleep?
Answer:
Waking up feeling fatigued and unrefreshed
Question:
What is the MOA of Rameltzon (remeron)
Answer:
M1 and M2 agonist (selective melatonin)
- / 4
Question:
What are non-pharmacologic treatments for sleep apnea?
Answer:
weight loss, avoidance of ETOH, CPAP, uvulopalatopharyngoplasty
Question:
What are some side effects of Zolpidem (Ambien)?
Answer:
antegrade amnesia, hallucinations, parasomnias (sleep walking and eating), increased fall risk, GI effects
Question:
What are treatments for RLS?
Answer:
Remove offending agent, iron replacement; 1st line= dopamine agonists (pramipexole and ropinirole); Gabapentin/pregabalin, benzos
Question:
What is the MOA of zolpidem?
Answer:
Selectively binds to Omega=1 receptor on GABA-A receptor (responsible for sedation)
- / 4